“Bionic eye” brain implants to be trialled in US
Thursday 19 October 2017In an exciting development, the U.S Food and Drug Administration (FDA) has given conditional approval to the makers of the world’s first commercial artificial retina to conduct a small-scale clinical trial of a brain implant designed to restore vision.
The development company, Second Sight, already produce the Argus II bionic eye which relays signals via a specially adapted pair of glasses to an external processor. The new device, named the Orion, is a modified version of the Argus II. It will relay messages directly to the visual cortex of the brain using an array of surgically-implanted electrodes.
The clinical trial will involve five US-based patients, and Second Sight hope to have implanted the devices by December 2017. Robert Greenberg, Second Sight’s board chair, sees massive potential in the new development, claiming that “anyone who had vision but has lost it from almost any cause could potentially be helped by the Orion technology.”
Sources:
Comments
Post a comment…
A Serious Blog
News and views from around the world on lighting, eyecare and eye conditions.
Twitter: @seriousreaders
Facebook:facebook.com/seriousreaders
Recent posts
- Living with Glaucoma: National Eye Health Week
- The role of light in painting the sky blue
- Five essential summer eye care tips: How to take care of your eyes this summer
- The history of lighting at Wimbledon: A tale of illumination, innovation, and tradition
- From the Chelsea Flower Show to your home: The power of light in plant growth
Don't miss out on exclusive content and all the latest in light and sight. Subscribe to our email list now!